Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma.
about
Kallikreins as biomarkers for prostate cancerProstate cancer: ESMO Consensus Conference Guidelines 2012Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in AsiaA panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden.Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomy.Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden.Racial differences in PSA screening interval and stage at diagnosis.Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohortProstate-specific antigen screening in prostate cancer: perspectives on the evidenceCombining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer.Prostate kallikrein markers in diagnosis, risk stratification and prognosis.Individualized screening interval for prostate cancer based on prostate-specific antigen level: results of a prospective, randomized, population-based study.Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in SwedenProstate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsyTo be screened or not to be screened? Modeling the consequences of PSA screening for the individualExcess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East AngliaA model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival.Treatment of local-regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factorsCan one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?Increase in percent free prostate-specific antigen in men with chronic kidney disease.Prostate specific antigen for early detection of prostate cancer: longitudinal study.Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancerGeographical variation in incidence of prostate cancer in Sweden.Prevalence and clinical significance of prostate cancer among 12,682 men with normal digital rectal examination, low PSA levels (< or =4 ng/ml) and percent free PSA cutoff values of 15 and 20%.Incidence of insignificant prostate cancer using free/total PSA: results of a case-finding protocol on 14,453 patients.Cost-effectiveness of Prostate Health Index for prostate cancer detection.Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan.Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate-specific antigen level > or =50 ng/mL.Comparative effectiveness of platinum-based chemotherapy versus taxane and other regimens for ovarian cancer.Uptake of prostate-specific antigen testing for early prostate cancer detection in Sweden.Results of the three rounds of the Finnish Prostate Cancer Screening Trial--the incidence of advanced cancer is decreased by screening.Clinical characteristics and prostate-specific antigen kinetics of prostate cancer detected in repeat annual population screening in Japan.Budget impact analysis of a new prostate cancer risk index for prostate cancer detection.Racial disparities in prostate cancer survival in a screened population: Reality versus artifact.Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial
P2860
Q26862434-B1D7356E-EEAB-4577-B861-36B8F8DC7173Q27022847-64AFA8B9-A29E-47CE-821D-63FD0A7B1BC9Q28085419-6B8F86BB-7DE9-43C8-A04E-E5A71DC107B8Q31161981-780469FD-958E-4822-AD1F-C3FF1678737CQ33379156-3BDA77C1-956F-424A-BD07-062AD1612504Q33545711-804A02E2-5D91-447F-852B-28FFC422F458Q33905826-EF190E08-60A8-41D7-832E-714728893D67Q33937634-6ABAA4D4-D346-48E4-BEE7-66107D74A0B5Q34354430-8113B0D0-23AE-4348-B50B-7CD46009ED9CQ35535776-38EB6188-1D0C-48C3-85C1-8E4636E7C778Q35683035-5265428D-802D-4F31-86D1-9592F8A806B6Q35945224-776D3EE8-517C-43F3-97AE-83B5BA6FBEC3Q35948229-EB4A6250-F1BD-40E7-ADE8-658C7AA27D2AQ36142278-69E1A668-EC12-4C4A-AF39-317BB24CA603Q36184260-AB9A3E76-0DD1-4827-8D77-DF5CA25E7A4FQ36612163-FEFFBF17-327A-4E9A-872E-6D46772DDDBFQ36614192-1E372CD5-CE5C-406D-A2C1-F4B785B21132Q36896116-A03B5086-BA40-4176-B4D4-98A10615E930Q36909145-7060DFE9-55EF-4394-BF2E-DB365035F145Q37290774-4B356648-B8D2-4C7F-BB0D-D1E87E940DC8Q37362535-9D3C1E43-4347-4454-9A88-CD2E4422C58EQ37422990-8F8B6479-96EE-434C-8693-D4309CDEF3DCQ39734785-09C6BC57-A2BB-4348-B083-0BAB40F46334Q39796854-DB2F6425-BC93-45D9-8A9C-CEFCFFA045E7Q39946224-8A4F5CFD-3989-417D-9DDD-3F23254EE626Q40007049-443E076B-30F5-4CDE-B239-7D413DFF27EAQ41861697-ED91CAFF-E177-4A44-82B6-681FB3B33C28Q42049239-47E0C1BE-F3C4-44EE-B168-8BE02D1107E1Q43508505-BD842BE4-7491-4A92-936F-4916E5602D8BQ43581669-64CFDF74-56DE-4B7B-9A73-527D014A563DQ43814269-89D01416-D570-457F-8623-A731785A6776Q44483421-C3E7E444-1B09-45C7-B8E8-8359BFCDFBFAQ46098777-87EBC463-BF59-4FF8-AF71-0EB755D4AB29Q48165110-C708C250-6664-4CD9-93A7-8ED02CF7883DQ57101962-D4ED4FFF-1C07-46DB-97F9-66EFCFFE889F
P2860
Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Results of a randomized, popul ...... to detect prostate carcinoma.
@en
Results of a randomized, popul ...... to detect prostate carcinoma.
@nl
type
label
Results of a randomized, popul ...... to detect prostate carcinoma.
@en
Results of a randomized, popul ...... to detect prostate carcinoma.
@nl
prefLabel
Results of a randomized, popul ...... to detect prostate carcinoma.
@en
Results of a randomized, popul ...... to detect prostate carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Results of a randomized, popul ...... to detect prostate carcinoma.
@en
P2093
Carl-Gustav Pihl
Gunnar Aus
Jonas Hugosson
Pär Lodding
P2860
P304
P356
10.1002/CNCR.20126
P407
P50
P577
2004-04-01T00:00:00Z